Rare diseases
Investigational molecules
Locations
Back to Austria8 clinical trials in Feldbach, Austria. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of Brenipatide (LY3537031) in Adults with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
AustriaStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
AustriaStudy on Dapagliflozin for Patients with Chronic Kidney Disease or Kidney Failure Undergoing Hemodialysis
AustriaStudy on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
AustriaStudy on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
AustriaStudy on Benralizumab for Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) with Frequent Exacerbations
AustriaStudy of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups
AustriaStudy Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma
AustriaThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on severe asthma and its treatment through innovative therapies. Studies are evaluating new approaches for patients with eosinophilic phenotype who have previously responded to specific treatments.
These trials aim to improve long-term outcomes for patients with severe respiratory conditions.
Comprehensive studies examining chronic obstructive pulmonary disease treatments, including evaluation of triple therapy combinations and novel therapeutic approaches.
Research focuses on improving quality of life and reducing severe cardiopulmonary outcomes.
Important research investigating treatments for patients with chronic kidney disease and those requiring hemodialysis, with a focus on cardiovascular outcomes.
These trials aim to enhance treatment options for patients with complex kidney conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
